Since the first case of Ebola appeared last year, the virus has infected nearly 10,000 people. The epidemic is concentrated in Liberia, Sierra Leone, and Guinea — post-conflict countries with incredibly weak health systems.
The priority for policymakers concerned about the Ebola epidemic in West Africa should be to respond to the existing outbreak, treat the victims, and contain its spread. But the longer term lesson is that we need to be willing to spend more on global health.
This Wonkcast was originally recorded on September 2, 2014.
As the Ebola epidemic continued to spread in West Africa, with more than 3,000 cases and 1,500 deaths, I invited CGD senior fellow Mead Over, a health economist and one of the world’s top experts on the economics of HIV/AIDS, to discuss newly released maps from the World Health Organization (WHO) and measures for limiting the economic fallout from the epidemic.
On September 23, the Washington Post aired a disagreement between the US Center for Disease Control Ebola experts and the Médecins Sans Frontieres Ebola doctors regarding the value of community Ebola treatment centers staffed with community volunteers for Liberia, Guinea, and Sierra Leone.
With the threat of antimicrobial resistance on the rise, we are heartened by President Barack Obama’s recent executive order that outlines a national strategy to combat drug resistance, including creation of an inter-agency task force to implement and monitor the plan. The Centers for Disease Control and Prevention estimate that up to 2 million Americans suffer from antibiotic-resistant infections each year and that 23,000 of them die.